Paul Berns
VCManaging Director, ARCH Venture Partners
Pharma CEO turned early biotech company builder
Background
Paul Berns is a Managing Director at ARCH Venture Partners with over 30 years of pharma and biopharma experience. He previously served as Chairman, President and CEO of Anacor Pharmaceuticals (acquired by Pfizer for $5.2 billion), President and CEO of Allos Therapeutics, and President and CEO of Bone Care International. Earlier he held senior roles at Abbott Laboratories, BASF Pharmaceuticals/Knoll, and Bristol-Myers Squibb. He currently serves on the boards of Unity Biotechnology, EQRX, and chairs Epirium Bio.
Investment Thesis
Late-clinical and early-commercial stage biopharma companies where operational experience can accelerate the path to patients.
Investment Focus
Stages
Sectors
Based in: Chicago, IL (North America)